Cargando…

The Pharmaceutical Industry and the Canadian Government: Folie à Deux

The interest of the pharmaceutical industry is in achieving a profit for its shareholders while the interest of the Canadian government should be in protecting public health. However, over the course of the past few decades the actions of the Canadian government have been tilted in favour of industr...

Descripción completa

Detalles Bibliográficos
Autor principal: Lexchin, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Longwoods Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595210/
https://www.ncbi.nlm.nih.gov/pubmed/28906232
http://dx.doi.org/10.12927/hcpol.2017.25195
_version_ 1783263331338944512
author Lexchin, Joel
author_facet Lexchin, Joel
author_sort Lexchin, Joel
collection PubMed
description The interest of the pharmaceutical industry is in achieving a profit for its shareholders while the interest of the Canadian government should be in protecting public health. However, over the course of the past few decades the actions of the Canadian government have been tilted in favour of industry in two areas. The first is in the relationship between industry and Health Canada and is manifested in the regulation of clinical trials, the drug approval system, drug safety and promotion. The second is in economic policy as it applies to policies about patent protection, the price of medications and measures taken to incentivize research and development. The problems in the relationship are structural and will only be solved through systemic changes.
format Online
Article
Text
id pubmed-5595210
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Longwoods Publishing
record_format MEDLINE/PubMed
spelling pubmed-55952102018-08-01 The Pharmaceutical Industry and the Canadian Government: Folie à Deux Lexchin, Joel Healthc Policy Discussion and Debate The interest of the pharmaceutical industry is in achieving a profit for its shareholders while the interest of the Canadian government should be in protecting public health. However, over the course of the past few decades the actions of the Canadian government have been tilted in favour of industry in two areas. The first is in the relationship between industry and Health Canada and is manifested in the regulation of clinical trials, the drug approval system, drug safety and promotion. The second is in economic policy as it applies to policies about patent protection, the price of medications and measures taken to incentivize research and development. The problems in the relationship are structural and will only be solved through systemic changes. Longwoods Publishing 2017-08 /pmc/articles/PMC5595210/ /pubmed/28906232 http://dx.doi.org/10.12927/hcpol.2017.25195 Text en Copyright © 2017 Longwoods Publishing http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 License, which permits rights to copy and redistribute the work for non-commercial purposes only, provided the original work is given proper attribution.
spellingShingle Discussion and Debate
Lexchin, Joel
The Pharmaceutical Industry and the Canadian Government: Folie à Deux
title The Pharmaceutical Industry and the Canadian Government: Folie à Deux
title_full The Pharmaceutical Industry and the Canadian Government: Folie à Deux
title_fullStr The Pharmaceutical Industry and the Canadian Government: Folie à Deux
title_full_unstemmed The Pharmaceutical Industry and the Canadian Government: Folie à Deux
title_short The Pharmaceutical Industry and the Canadian Government: Folie à Deux
title_sort pharmaceutical industry and the canadian government: folie à deux
topic Discussion and Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595210/
https://www.ncbi.nlm.nih.gov/pubmed/28906232
http://dx.doi.org/10.12927/hcpol.2017.25195
work_keys_str_mv AT lexchinjoel thepharmaceuticalindustryandthecanadiangovernmentfolieadeux
AT lexchinjoel pharmaceuticalindustryandthecanadiangovernmentfolieadeux